0000059478-23-000320.txt : 20231219
0000059478-23-000320.hdr.sgml : 20231219
20231219161019
ACCESSION NUMBER: 0000059478-23-000320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231218
FILED AS OF DATE: 20231219
DATE AS OF CHANGE: 20231219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fyrwald J Erik
CENTRAL INDEX KEY: 0001343564
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06351
FILM NUMBER: 231497408
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELI LILLY & Co
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
FORMER COMPANY:
FORMER CONFORMED NAME: LILLY ELI & CO
DATE OF NAME CHANGE: 19941024
4
1
wk-form4_1703020205.xml
FORM 4
X0508
4
2023-12-18
0
0000059478
ELI LILLY & Co
LLY
0001343564
Fyrwald J Erik
LILLY CORPORATE CENTER
INDIANAPOLIS
IN
46285
1
0
0
0
0
Common Stock
2023-12-18
4
A
0
17
579.76
A
71886
D
At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
/s/ Christopher Anderson for J. Erik Fyrwald, pursuant to authorization on file
2023-12-19